Elite Pharmaceuticals Inc (ELTP)

[Pharma Sleuth]

It's really not complicated. Growth on current products is slowing after the launches of rhese. products.

We did what 17.5...

So let's say

17.5
18.5
20
22

That's hedging your bets at 78m. And roughly another 50% YOY. That's the "slow" growth.

Can you imagine? Slow growth is 50% YOY..lol

Stop looking at Q to Q. It's nice but affected by late or early shipments.

Now let's say we can launch the approved drugs in 3-6 months. Stability, packaging, inspections , FDA. Xfer... That revenue will come q3 and q4 maybe Q2 if everything goes fast.

Play it safe and you say, we don't really know yet so let's stay with the growth we have and predicts 70s.

Here is why none of this matters. This is the only pharma company that looks backwards. Low PE so the stock should have a much higher PE based on the next 1-3 years.

That's why a drug trial, filing or an approval moves pharma stocks. Not the actual revenue.

One day we will look forward. In the meantime they just keep making money.